Christoph A. Seyfried

Author

Also Known As

C SEYFRIED, C Seyfried, C. A. SEYFRIED, C. A. Seyfried, C. SEYFRIED, C. Seyfried, C.A. Seyfried, C.A. Seyfried,, Christoph A. Seyfried, Christoph Seyfried

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Merck (Germany)Karolinska Institutet Merck (France)

About

Christoph A. Seyfried is an author at Merck (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	806
2	Natural Sciences	8	8	389
3	Biochemistry	8	8	389
4	Social Sciences	7	7	308
5	Engineering	1	1	88

Christoph A. Seyfried

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
A pharmacological profile of the novel, peripherally‐selective<i>k</i>‐opioid receptor agonist, EMD 61753 Andrew Barber, Gerd D. Bartoszyk, H.M. Bender, British Journal of Pharmacology	1994	126
New (Sulfonyloxy)piperazinyldibenzazepines as Potential Atypical Antipsychotics: Chemistry and Pharmacological Evaluation Yi Liao, Bastiaan J. Venhuis, Nienke Rodenhuis, Journal of Medicinal Chemistry Psychotropic MedicationPsychopharmacologyPharmacotherapySocial SciencesMedicinal Chemistry	1999	121
Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT<sub>1A</sub> Receptor Agonists and Serotonin Reuptake Inhibitors Timo Heinrich, Henning Böttcher, R. Gericke, Journal of Medicinal Chemistry PharmacotherapyChemistryExperimental PharmacologyPharmaceutical ChemistryMolecular Pharmacology	2004	114
Delivery of nanoparticles to the brain detected by fluorescence microscopy Isolde Reimold, Diana Domke, Joe Bender, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineFluorescence MicroscopyEngineeringNanobiotechnology	2008	88
Sarizotan, a serotonin 5-HT 1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile Gerd D. Bartoszyk, Christoph van Amsterdam, Hartmut E. Greiner, Journal of Neural Transmission Molecular PharmacologyNeurochemical ProfileSerotonin 5-Ht 1AMedicineNeurotransmitter	2004	75
Effects of sarizotan on the corticostriatal glutamate pathways Tiziana Antonelli, Kjell Fuxé, Maria Cristina Tomasini, Synapse	2005	73
5-HT Reuptake Inhibitors with 5-HT<sub>1B/1D</sub>Antagonistic Activity: A New Approach toward Efficient Antidepressants Lisa Matzen, Christoph van Amsterdam, Wilfried Rautenberg, Journal of Medicinal Chemistry Psychotropic MedicationPharmacotherapyExperimental PharmacologyMolecular PharmacologyMedicinal Chemistry	2000	66
Sila-Analogues of High-Affinity, Selective σ Ligands of the Spiro[indane-1,4‘-piperidine] Type: Syntheses, Structures, and Pharmacological Properties Reinhold Tacke, V.I. Handmann, Rüdiger Bertermann, Organometallics	2003	62
An automated direct‐injection HPLC‐method for the electrochemical/fluorimetric quantitation of monoamines and related compounds optimized for the screening of large numbers of animals Christoph A. Seyfried, Georg Adam, T. R. Greve Biomedical Chromatography Automated Direct‐injection Hplc‐methodSerotonin TurnoverRelated CompoundsStable Hplc SystemMedicinal Chemistry	1986	54
Biochemical and functional studies on EMD 49 980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems Christoph A. Seyfried, Hartmut E. Greiner, A Haase European Journal of Pharmacology Functional StudiesNeurophysiologyMedicinePhysiologyNeurotransmitter	1989	48

Page 1